With a passion for innovating technology and a clear understanding of business dynamics, Qbic supports researchers and entrepreneurs in transforming technological breakthroughs into successful companies.
AmphiStar offers a portfolio of locally sourced biosurfactants to companies seeking to develop sustainable, performant & affordable products
Obulytix develops the next generation of enzyme-based antibiotics inspired by nature.
Axithra is developing new technology for accurate drug concentrations in blood.
"Our goal at VoxelSensors is to seamlessly integrate the physical and digital worlds to a point level where they become indistinguishable."
VoxelSensors is developing ultra-low power and ultra-low latency 3D perception sensors for Extended Reality.
Animab develops antibodies to tackle gastrointestinal pathogens in livestock.
Weave.ly helps companies test and validate digital products before launch.
THERAtRAME develops and positions new therapeutics targeting tRNA epitranscriptomics in cancer.
"Swave’s HXR gigapixel technology will forever change the way we see and experience displayed still images, videos and live imaging."
Swave develops holographic eXtended reality technology to make virtual reality practically indistinguishable from the real world.
Cascador Health bridges the gap between data sources and the users of healthcare data.
"Our technology has the potential to enhance the therapeutic effectiveness of cell-based therapies and make them more affordable.”
Trince developed a new transfection technology based on a combination of laser light and photothermal nanoparticles.
CrowdScan provides accurate and privacy-friendly crowd measurement data.
"As the first-ever digital health app to be reimbursed in Belgium, we are setting the standard for healthcare’s transition to value-based (digital) care."
moveUP develops personalized remote digital care for patients undergoing surgery and other interventions.
Accelleran provides OpenRAN Software solutions for operators of 5G networks.
ABSCINT is developing single-domain antibodies for disease diagnosis through imaging.
"Managing diabetes should be as easy as possible, and that is what we want to help accomplish."
Indigo is developing an implantable sensor that allows to continuously measure glucose and other metabolites for up to two years.
MRM Health is developing a novel type of therapeutics based on beneficial intestinal bacteria.
"MicroLED displays could take out all the currently available display types. It would be great if QustomDot could facilitate this.”
QustomDot is developing cadmium-free quantum dots that are stable enough for advanced applications.
Calltic developed an acoustic analysis method allowing to quickly and accurately detect telecom fraud.
"There was no equipment on the market to manufacture implants at a micrometer dimension, so we built it ourselves."
UniD Manufacturing is developing and manufacturing micro-implants.
EyeD Pharma is developing micro-implants for drug release over a prolonged period of time.